Works matching IS 09024441 AND DT 2022 AND VI 109 AND IP 2

Results: 10

Acquired aplastic anemia following SARS‐CoV‐2 vaccination.

Published in:

European Journal of Haematology, 2022, v. 109, n. 2, p. 186, doi. 10.1111/ejh.13788

By:

Röth, Alexander;
Bertram, Stefanie;
Schroeder, Thomas;
Haverkamp, Thomas;
Voigt, Sebastian;
Holtkamp, Caroline;
Klump, Hannes;
Wörmann, Bernhard;
Reinhardt, Hans Christian;
Alashkar, Ferras

Publication type:

Article

Lower levels of cyclosporine between days 0 and +21 may reduce later relapses without increasing graft‐versus‐host disease in children and adolescents with acute lymphoblastic leukemia who undergo myeloablative TBI‐based allogeneic hematopoietic cell transplantation

Published in:

European Journal of Haematology, 2022, v. 109, n. 2, p. 182, doi. 10.1111/ejh.13787

By:

Arcuri, Leonardo Javier;
Lerner, Decio;
Tavares, Rita de Cassia Barbosa da Silva

Publication type:

Article

Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review.

Published in:

European Journal of Haematology, 2022, v. 109, n. 2, p. 166, doi. 10.1111/ejh.13786

By:

Salter, Brittany;
Burns, Ian;
Fuller, Katherine;
Eshaghpour, Ali;
Lionel, Anath C.;
Crowther, Mark

Publication type:

Article

Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long‐term prophylaxis: An expert opinion paper from an Italian panel.

Published in:

European Journal of Haematology, 2022, v. 109, n. 2, p. 121, doi. 10.1111/ejh.13785

By:

Castaman, Giancarlo;
Borchiellini, Alessandra;
Coppola, Antonio;
Cultrera, Dorina;
Marino, Renato;
Federici, Augusto B.;
Giuffrida, Anna Chiara;
Marchesini, Emanuela;
Molinari, Angelo Claudio;
Maria, Siboni Simona;
Zanon, Ezio

Publication type:

Article

Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma in the real world.

Published in:

European Journal of Haematology, 2022, v. 109, n. 2, p. 162, doi. 10.1111/ejh.13784

By:

Vodicka, Prokop;
Benesova, Katerina;
Janikova, Andrea;
Prochazka, Vit;
Belada, David;
Mocikova, Heidi;
Steinerova, Katerina;
Duras, Juraj;
Karban, Josef;
Hanackova, Veronika;
Sykorova, Alice;
Obr, Ales;
Trneny, Marek

Publication type:

Article

Real‐world data on voxelotor to treat patients with sickle cell disease.

Published in:

European Journal of Haematology, 2022, v. 109, n. 2, p. 154, doi. 10.1111/ejh.13782

By:

Muschick, Kathryn;
Fuqua, Tranaka;
Stoker‐Postier, Carrianne;
Anderson, Alan R.

Publication type:

Article

Circulating endothelial cells and endothelial progenitor cells as potential predictors of acute GVHD after allogeneic hematopoietic stem cell transplantation.

Published in:

European Journal of Haematology, 2022, v. 109, n. 2, p. 146, doi. 10.1111/ejh.13781

By:

Takamatsu, Akiko;
Nakashima, Yasuhiro;
Haji, Shojiro;
Tsuda, Mariko;
Masuda, Toru;
Kimura, Daisaku;
Shiratsuchi, Motoaki;
Ogawa, Yoshihiro

Publication type:

Article

Haematology Outcomes Network in Europe (HONEUR)—A collaborative, interdisciplinary platform to harness the potential of real‐world data in hematology.

Published in:

European Journal of Haematology, 2022, v. 109, n. 2, p. 138, doi. 10.1111/ejh.13780

By:

Bardenheuer, Kristina;
Van Speybroeck, Michel;
Hague, Clare;
Nikai, Enkeleida;
Price, Martin

Publication type:

Article

Validation of the HScore and the HLH‐2004 diagnostic criteria for the diagnosis of hemophagocytic lymphohistiocytosis in a multicenter cohort.

Published in:

European Journal of Haematology, 2022, v. 109, n. 2, p. 129, doi. 10.1111/ejh.13779

By:

Bilston, Lisa;
Croden, Jennifer;
Taparia, Minakshi;
Karkhaneh, Mohammad;
Grossman, Jennifer;
Sun, Haowei

Publication type:

Article

Issue Information.

Published in:: European Journal of Haematology, 2022, v. 109, n. 2, p. 119, doi. 10.1111/ejh.13658
Publication type:: Article